Andreas Mohr
YOU?
Author Swipe
View article: New dual dye for vitreoretinal surgery with increased transparency
New dual dye for vitreoretinal surgery with increased transparency Open
Objectives To develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use. Methods and analysis A new blue dye, DDG, was synthesise…
View article: Development and Implementation of a Multi-Channel Active Control System for the Reduction of Road Induced Vehicle Interior Noise
Development and Implementation of a Multi-Channel Active Control System for the Reduction of Road Induced Vehicle Interior Noise Open
An optimized driving comfort with a low interior noise level is an important intention in the passenger car development process. The interior noise level caused by the dynamic interaction between the rolling tyre and the rough road surface…
View article: Surveillance study on the tolerability and safety of Flebogamma<sup>®</sup><scp>DIF</scp> (10% and 5% intravenous immunoglobulin) in adult and pediatric patients
Surveillance study on the tolerability and safety of Flebogamma<sup>®</sup><span>DIF</span> (10% and 5% intravenous immunoglobulin) in adult and pediatric patients Open
Direct comparisons of tolerability and safety of concentrated intravenous immunoglobulin ( IVIG ) versus less concentrated products are scarce. In this postauthorization, prospective, observational, multicenter study, a systematic comparis…
View article: Erratum to: Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
Erratum to: Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial Open
View article: Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial Open
View article: A parallel panning scheme used for selection of a GluA4-specific Fab targeting the ligand-binding domain
A parallel panning scheme used for selection of a GluA4-specific Fab targeting the ligand-binding domain Open